Ryan Wong
Fortuna: 205 827 $ al 31/05/2026
Fortuna: 205 827 $ al 31/05/2026
Ryan Wong is currently Chief Financial Officer & Executive VP at Sarepta Therapeutics, Inc., a position held since 2025.
Education history includes an undergraduate degree from the University of California, Irvine, and a graduate degree from USC Marshall School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2026 | 11.518 ( 0,01 % ) | 205 827 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Director Financiero/CFO | 16/07/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.